| Not Yet Recruiting | A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterol Non-familial Hypercholesterolemia and Mixed Hyperlipidemia | Phase 3 | 2026-03-31 |
| Not Yet Recruiting | A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Heterozygous Familial Hypercholesterolemia (HeFH) | Phase 3 | 2026-03-31 |
| Recruiting | A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial H Non-familial Hypercholesterolemia and Mixed Hyperlipidemia | Phase 3 | 2026-02-28 |
| Not Yet Recruiting | A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of S Healthy Subjects | Phase 1 | 2025-11-24 |
| Recruiting | A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of S Healthy Subjects (HS) | Phase 1 | 2025-11-15 |
| Recruiting | Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Bioequivalence | Phase 1 | 2025-06-26 |
| Recruiting | Study of SYH2062 Injection in Healthy Chinese Volunteers Healthy Chinese Volunteers | Phase 1 | 2025-03-01 |
| Completed | A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterol Hypercholesterolemia and Mixed Hyperlipidemia | Phase 2 | 2024-12-03 |
| Not Yet Recruiting | Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting Post-operative Nausea and Vomiting (PONV) | Phase 3 | 2024-10-28 |
| Recruiting | A Bioequivalence Study of PP3M in Patients With Schizophrenia Schizophrenia | N/A | 2024-10-09 |
| Completed | A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of S Hyperlipemia | Phase 1 | 2024-01-08 |
| Not Yet Recruiting | A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-R High-risk (Secondary) Acute Myeloid Leukemia | Phase 3 | 2024-01-01 |
| Completed | Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophrenia Schizophrenia | N/A | 2023-12-18 |
| Unknown | A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection Acute Myeloid Leukemia | N/A | 2023-08-25 |
| Completed | Bioequivalence of Amphotericin B Liposome for Injection Bioequivalence | Phase 1 | 2023-06-02 |
| Unknown | A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergen Hypertensive Emergency | Phase 3 | 2023-05-01 |
| Not Yet Recruiting | Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Recurrent Metastatic Nasopharyngeal Carcinoma | Phase 3 | 2023-02-01 |
| Completed | Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder | Phase 2 | 2022-11-28 |
| Withdrawn | A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis Relapsing Multiple Sclerosis | Phase 2 | 2022-08-01 |
| Unknown | Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM Relapsed or Refractory Multiple Myeloma | Phase 1 | 2021-10-20 |
| Unknown | Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients Acute Myeloid Leukemia | N/A | 2020-09-04 |
| Completed | A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects Bioequivalence | Phase 1 | 2020-06-04 |